Capital Counsel’s Amgen AMGN Stock Holding History

Capital Counsel’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$241K	Hold	666	–	–	0.01%	55
2026 Q1	$234K	Hold	666	–	–	0.01%	55
2025 Q4	$218K	Buy	+666	New	+$211K	0.01%	56
2025 Q2	–	Sell	-686	Closed	-$214K	–	58
2025 Q1	$214K	Buy	+686	New	+$203K	0.01%	51
2024 Q4	–	Sell	-666	Closed	-$215K	–	56
2024 Q3	$215K	Hold	666	–	–	0.01%	52
2024 Q2	$208K	Buy	+666	New	+$196K	0.01%	50
2023 Q2	–	Sell	-1,625	Closed	-$393K	–	53
2023 Q1	$393K	Hold	1,625	–	–	0.02%	39
2022 Q4	$427K	Hold	1,625	–	–	0.03%	39
2022 Q3	$366K	Hold	1,625	–	–	0.02%	43
2022 Q2	$395K	Hold	1,625	–	–	0.02%	42
2022 Q1	$393K	Hold	1,625	–	–	0.02%	46
2021 Q4	$366K	Hold	1,625	–	–	0.02%	47
2021 Q3	$346K	Hold	1,625	–	–	0.02%	47
2021 Q2	$396K	Sell	1,625 -100	-6%	-$24.6K	0.02%	48
2021 Q1	$429K	Hold	1,725	–	–	0.02%	50
2020 Q4	$397K	Hold	1,725	–	–	0.02%	48
2020 Q3	$438K	Hold	1,725	–	–	0.03%	43
2020 Q2	$407K	Buy	1,725 +100	+6%	+$22.8K	0.03%	42
2020 Q1	$329K	Hold	1,625	–	–	0.03%	45
2019 Q4	$392K	Hold	1,625	–	–	0.03%	46
2019 Q3	$314K	Hold	1,625	–	–	0.02%	48
2019 Q2	$299K	Hold	1,625	–	–	0.02%	51
2019 Q1	$309K	Sell	1,625 -97	-6%	-$18.5K	0.02%	50
2018 Q4	$335K	Hold	1,722	–	–	0.03%	47
2018 Q3	$357K	Hold	1,722	–	–	0.02%	52
2018 Q2	$318K	Sell	1,722 -144	-8%	-$25.5K	0.02%	50
2018 Q1	$318K	Hold	1,866	–	–	0.03%	52
2017 Q4	$324K	Hold	1,866	–	–	0.03%	51
2017 Q3	$348K	Hold	1,866	–	–	0.03%	47
2017 Q2	$321K	Sell	1,866 -465	-20%	-$75.6K	0.03%	49
2017 Q1	$382K	Buy	2,331 +165	+8%	+$27.4K	0.04%	49
2016 Q4	$317K	Hold	2,166	–	–	0.03%	47
2016 Q3	$361K	Buy	2,166 +666	+44%	+$113K	0.03%	46
2016 Q2	$228K	Sell	1,500 -6,000	-80%	-$933K	0.02%	52
2016 Q1	$1.12M	Sell	7,500 -2,415	-24%	-$359K	0.1%	30
2015 Q4	$1.61M	Sell	9,915 -1,977	-17%	-$311K	0.09%	48
2015 Q3	$1.65M	Sell	11,892 -15	-0.1%	-$2.36K	0.09%	48
2015 Q2	$1.83M	Sell	11,907 -139	-1%	-$22.3K	0.09%	49
2015 Q1	$1.93M	Hold	12,046	–	–	0.09%	48
2014 Q4	$1.92M	Hold	12,046	–	–	0.09%	50
2014 Q3	$1.69M	Hold	12,046	–	–	0.1%	46
2014 Q2	$1.43M	Sell	12,046 -100	-0.8%	-$11.6K	0.08%	47
2014 Q1	$1.5M	Hold	12,146	–	–	0.08%	46
2013 Q4	$1.39M	Buy	12,146 +825	+7%	+$93.8K	0.08%	49
2013 Q3	$1.27M	Buy	11,321 +21	+0.2%	+$2.28K	0.07%	49
2013 Q2	$1.11M	Buy	+11,300	New	+$1.17M	0.07%	49

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Capital Counsel's AMGN Position: Q2 2026 in Review

Capital Counsel held its Amgen (AMGN) position steady in Q2 2026 at 666 shares worth $241K. The position accounts for 0.01% of the portfolio, ranked #55.

Capital Counsel first reported a position in AMGN in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.93M in Q1 2015. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Capital Counsel held 666 shares of Amgen worth $241K as of Q2 2026.
Capital Counsel left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.01% of Capital Counsel's portfolio in Q2 2026, its #55 holding.
Capital Counsel first reported a position in Amgen in Q2 2013 and has held it in 46 quarters since.
Capital Counsel's Amgen position peaked at $1.93M in Q1 2015.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Capital Counsel's 13F filing for Q2 2026, filed 12 Aug 2026.